News & Updates

Show Multimedia Only
Modern radiotherapy safe for heart in breast cancer patients

Modern radiotherapy safe for heart in breast cancer patients

17 May 2022 byTristan Manalac

Breast cancer patients see no excess risk of ischaemic heart disease (IHD)-related mortality after radiotherapy (RT) treatment, according to a recent Singapore study.

Modern radiotherapy safe for heart in breast cancer patients

17 May 2022
Starchy diets up T2D risk in women

Starchy diets up T2D risk in women

17 May 2022
Pelvic floor muscle exercises beneficial in postprostatectomy urinary incontinence

Pelvic floor muscle exercises beneficial in postprostatectomy urinary incontinence

17 May 2022
ED-dispensed mifepristone plus misoprostol improves access to early pregnancy loss care

ED-dispensed mifepristone plus misoprostol improves access to early pregnancy loss care

16 May 2022 byJairia Dela Cruz

Administering mifepristone and misoprostol in the emergency departments (EDs) appears to be effective, increasing the availability of early pregnancy loss medical management services to women during the COVID-19 pandemic in the US, as shown in a study presented at the 2022 American College of Obstetricians and Gynecologists (ACOG) Annual Clinical & Scientific Meeting.

ED-dispensed mifepristone plus misoprostol improves access to early pregnancy loss care

16 May 2022
Beta-blockers reduce mortality risk in older patients with HFrEF

Beta-blockers reduce mortality risk in older patients with HFrEF

16 May 2022

Use of beta-blockers results in a lower risk of all-cause mortality, but not of heart failure (HF) readmission, in older patients with HR with reduced ejection fraction (HFrEF), reports a recent study. Results are similar between patients admitted and not admitted from nursing homes.

Beta-blockers reduce mortality risk in older patients with HFrEF

16 May 2022